Evommune Competitors and Similar CompaniesClear all
Evommune's competitors and similar companies include CanSino Biologics and Athenex.
 CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. |  Athenex Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer. | ||
Founding Date | Founding Date 2020 | Founding Date 2009 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Palo Alto, US HQ | Locations Tianjin, CN HQ | |
Employees | Employees 4521% decrease | Employees 1,10526% decrease | Employees 575 |
Financial | |||
Revenue (est.) | Revenue (est.) $13m (FY, 2025) | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) $102.8m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods ¥81.4m (FY, 2025) | Cost of goods $76.1m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit ¥1.1b (FY, 2025) | Gross profit $26.7m (FY, 2022) |
Net income | Net income ($68.9m) (FY, 2025) | Net income ¥27.9m (FY, 2025) | Net income ($104.4m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 57.5m | Total funding raised $ 76m | Total funding raised $ 252.1m |
For sources of this data, please see the company profile
View Company Profiles
CanSino Biologics
HQ
Tianjin, CN
Employees
1,105↓ 26% decrease
CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
View companyAthenex
HQ
Buffalo, US
Employees
575
Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer.
View company